KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 139 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,890,000 | -28.6% | 814,250 | -26.8% | 3.56% | +3.6% |
| Q1 2022 | $11,058,000 | -8.3% | 1,112,500 | +8.5% | 3.43% | +34.2% |
| Q4 2021 | $12,064,000 | -19.1% | 1,025,000 | -21.8% | 2.56% | -8.2% |
| Q3 2021 | $14,921,000 | -7.3% | 1,310,000 | +13.4% | 2.79% | +4.3% |
| Q2 2021 | $16,092,000 | +170.9% | 1,155,200 | +260.0% | 2.67% | +206.5% |
| Q1 2021 | $5,940,000 | +50.0% | 320,926 | +43.2% | 0.87% | +68.7% |
| Q4 2020 | $3,960,000 | -54.9% | 224,100 | -33.7% | 0.52% | -69.9% |
| Q3 2020 | $8,778,000 | 0.0% | 338,000 | -1.9% | 1.72% | -3.2% |
| Q2 2020 | $8,778,000 | – | 344,500 | – | 1.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 2,474,561 | $42,983,125 | 5.17% |
| Rubric Capital Management LP | 3,077,449 | $53,455,289 | 2.00% |
| Parkman Healthcare Partners LLC | 509,810 | $8,855,400 | 1.62% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $10,422,000 | 1.47% |
| AlphaCentric Advisors LLC | 110,000 | $1,910,700 | 1.08% |
| Lion Point Capital, LP | 130,691 | $2,270,103 | 1.01% |
| RICE HALL JAMES & ASSOCIATES, LLC | 650,366 | $11,296,857 | 0.72% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 185,853 | $3,228,267 | 0.53% |
| ADVISORY RESEARCH INC | 204,098 | $3,545,182 | 0.49% |
| Jackson Creek Investment Advisors LLC | 65,607 | $1,140 | 0.48% |